Rhythmic Walking Program and Renal Function and Oxidative Stress

NCT ID: NCT07059559

Last Updated: 2025-07-11

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 64 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2024-07-17
• Study Completion Date: 2025-07-01

Brief Summary

This study designed a over-knee automatic step counter device. Then, we evaluated its efficacy on renal function and oxidative stress in patients with chronic kidney disease.

Detailed Description

This study is a randomized controlled trial. Patients who consent to participate and pass the screening process will be randomly assigned to groups based on the order of their participation (random by sequence). Patients who join in odd-numbered order, such as 1st, 3rd, 5th, etc., will receive standard care as provided by the hospital (control group). Patients who join in even-numbered order, such as 2nd, 4th, 6th, etc., will receive a walking program. This involves continuous walking exercise for 30 minutes, once a day, three days a week, over a period of three months. During the walking sessions, patients will walk at a pace of 60 steps per minute, or one step per second.

Conditions

Renal Function

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Study Groups

Control group

Patients who join in odd-numbered order, such as 1st, 3rd, 5th, etc., will receive standard care as provided by the hospital (control group).

Group Type: NO_INTERVENTION

No interventions assigned to this group

Rhythmic walking group

Patients who join in even-numbered order, such as 2nd, 4th, 6th, etc., will receive a walking program. This involves continuous walking exercise for 30 minutes, once a day, three days a week, over a period of three months. During the walking sessions, patients will walk at a pace of 60 steps per minute, or one step per second.

Group Type: EXPERIMENTAL

Rhythmic walking

Intervention Type: OTHER

Patients who consent to participate and pass the screening process were randomly assigned to groups based on the order of their participation (random by sequence): control group or rhythmic walking group.

Interventions

Rhythmic walking

Patients who consent to participate and pass the screening process were randomly assigned to groups based on the order of their participation (random by sequence): control group or rhythmic walking group.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Male or female
• Aged between 18 and 59 years
• Diagnosed by a physician with chronic kidney disease stage 2-4, with a glomerular filtration rate (GFR) between 15-89 milliliters per minute, persisting for at least 3 months

Exclusion Criteria

• No musculoskeletal disorders that hinder walking, such as osteoarthritis
• Not engaging in regular exercise (less than 3 times per week or less than 150 minutes per week)
• Not regularly taking medications or supplements containing antioxidants

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 59 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Burapha University

OTHER

Sponsor Role: lead

Responsible Party

Piyapong Prasertsri

Associate Professor Dr.

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Piyapong Prasertsri, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Faculty of Allied Health Sciences, Burapha University

Locations

Rehabilitation Medicine Department, Chamni Hospital

Chamni, Changwat Buri Ram, Thailand

Countries

Thailand

Other Identifiers

BRO 2024-074

Identifier Type: -

Identifier Source: org_study_id